3,5-dimethyl-4-propan-2-yl-1,2-oxazole;3,5-dimethyl-4-propan-2-yl-1,2-thiazole;3,5-dimethyl-4-propan-2-yl-1,2,4-triazole;1-methyl-2-propan-2-ylimidazole;3-methyl-4-propan-2-yl-1,2,5-oxadiazole;3-methyl-5-propan-2-yl-1,2,4-oxadiazole;5-methyl-3-propan-2-yl-1,2,4-oxadiazole;3-methyl-4-propan-2-yl-1,2-oxazole;4-methyl-5-propan-2-yl-1,3-oxazole;1-methyl-5-propan-2-yltetrazole;5-methyl-1-propan-2-yltetrazole;2-methyl-5-propan-2-yl-1,3,4-thiadiazole;3-methyl-5-propan-2-yl-1,2,4-thiadiazole;3-methyl-4-propan-2-yl-1,2-thiazole;1-methyl-5-propan-2-yltriazole;2-propan-2-yl-1,3-oxazole;5-propan-2-yl-1,3-oxazole;2-propan-2-yl-1,3-thiazole;4-propan-2-yl-3-(trifluoromethyl)-1,2-oxazole
C122H200F3N35O9S5 — CID 163722623
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3,5-dimethyl-4-propan-2-yl-1,2-oxazole;3,5-dimethyl-4-propan-2-yl-1,2-thiazole;3,5-dimethyl-4-propan-2-yl-1,2,4-triazole;1-methyl-2-propan-2-ylimidazole;3-methyl-4-propan-2-yl-1,2,5-oxadiazole;3-methyl-5-propan-2-yl-1,2,4-oxadiazole;5-methyl-3-propan-2-yl-1,2,4-oxadiazole;3-methyl-4-propan-2-yl-1,2-oxazole;4-methyl-5-propan-2-yl-1,3-oxazole;1-methyl-5-propan-2-yltetrazole;5-methyl-1-propan-2-yltetrazole;2-methyl-5-propan-2-yl-1,3,4-thiadiazole;3-methyl-5-propan-2-yl-1,2,4-thiadiazole;3-methyl-4-propan-2-yl-1,2-thiazole;1-methyl-5-propan-2-yltriazole;2-propan-2-yl-1,3-oxazole;5-propan-2-yl-1,3-oxazole;2-propan-2-yl-1,3-thiazole;4-propan-2-yl-3-(trifluoromethyl)-1,2-oxazole
3,5-dimethyl-4-propan-2-yl-1,2-oxazole;3,5-dimethyl-4-propan-2-yl-1,2-thiazole;3,5-dimethyl-4-propan-2-yl-1,2,4-triazole;1-methyl-2-propan-2-ylimidazole;3-methyl-4-propan-2-yl-1,2,5-oxadiazole;3-methyl-5-propan-2-yl-1,2,4-oxadiazole;5-methyl-3-propan-2-yl-1,2,4-oxadiazole;3-methyl-4-propan-2-yl-1,2-oxazole;4-methyl-5-propan-2-yl-1,3-oxazole;1-methyl-5-propan-2-yltetrazole;5-methyl-1-propan-2-yltetrazole;2-methyl-5-propan-2-yl-1,3,4-thiadiazole;3-methyl-5-propan-2-yl-1,2,4-thiadiazole;3-methyl-4-propan-2-yl-1,2-thiazole;1-methyl-5-propan-2-yltriazole;2-propan-2-yl-1,3-oxazole;5-propan-2-yl-1,3-oxazole;2-propan-2-yl-1,3-thiazole;4-propan-2-yl-3-(trifluoromethyl)-1,2-oxazole (PubChem CID 163722623) has the molecular formula C122H200F3N35O9S5 and a molecular weight of 2518.51 g/mol. Its IUPAC name is 3,5-dimethyl-4-propan-2-yl-1,2-oxazole;3,5-dimethyl-4-propan-2-yl-1,2-thiazole;3,5-dimethyl-4-propan-2-yl-1,2,4-triazole;1-methyl-2-propan-2-ylimidazole;3-methyl-4-propan-2-yl-1,2,5-oxadiazole;3-methyl-5-propan-2-yl-1,2,4-oxadiazole;5-methyl-3-propan-2-yl-1,2,4-oxadiazole;3-methyl-4-propan-2-yl-1,2-oxazole;4-methyl-5-propan-2-yl-1,3-oxazole;1-methyl-5-propan-2-yltetrazole;5-methyl-1-propan-2-yltetrazole;2-methyl-5-propan-2-yl-1,3,4-thiadiazole;3-methyl-5-propan-2-yl-1,2,4-thiadiazole;3-methyl-4-propan-2-yl-1,2-thiazole;1-methyl-5-propan-2-yltriazole;2-propan-2-yl-1,3-oxazole;5-propan-2-yl-1,3-oxazole;2-propan-2-yl-1,3-thiazole;4-propan-2-yl-3-(trifluoromethyl)-1,2-oxazole.
Molecular Properties
| Compound Name | 3,5-dimethyl-4-propan-2-yl-1,2-oxazole;3,5-dimethyl-4-propan-2-yl-1,2-thiazole;3,5-dimethyl-4-propan-2-yl-1,2,4-triazole;1-methyl-2-propan-2-ylimidazole;3-methyl-4-propan-2-yl-1,2,5-oxadiazole;3-methyl-5-propan-2-yl-1,2,4-oxadiazole;5-methyl-3-propan-2-yl-1,2,4-oxadiazole;3-methyl-4-propan-2-yl-1,2-oxazole;4-methyl-5-propan-2-yl-1,3-oxazole;1-methyl-5-propan-2-yltetrazole;5-methyl-1-propan-2-yltetrazole;2-methyl-5-propan-2-yl-1,3,4-thiadiazole;3-methyl-5-propan-2-yl-1,2,4-thiadiazole;3-methyl-4-propan-2-yl-1,2-thiazole;1-methyl-5-propan-2-yltriazole;2-propan-2-yl-1,3-oxazole;5-propan-2-yl-1,3-oxazole;2-propan-2-yl-1,3-thiazole;4-propan-2-yl-3-(trifluoromethyl)-1,2-oxazole |
|---|---|
| PubChem CID | 163722623 |
| Molecular Formula | C122H200F3N35O9S5 |
| Molecular Weight | 2518.51 g/mol |
| Exact Mass | 2516.48 |
| IUPAC Name | 3,5-dimethyl-4-propan-2-yl-1,2-oxazole;3,5-dimethyl-4-propan-2-yl-1,2-thiazole;3,5-dimethyl-4-propan-2-yl-1,2,4-triazole;1-methyl-2-propan-2-ylimidazole;3-methyl-4-propan-2-yl-1,2,5-oxadiazole;3-methyl-5-propan-2-yl-1,2,4-oxadiazole;5-methyl-3-propan-2-yl-1,2,4-oxadiazole;3-methyl-4-propan-2-yl-1,2-oxazole;4-methyl-5-propan-2-yl-1,3-oxazole;1-methyl-5-propan-2-yltetrazole;5-methyl-1-propan-2-yltetrazole;2-methyl-5-propan-2-yl-1,3,4-thiadiazole;3-methyl-5-propan-2-yl-1,2,4-thiadiazole;3-methyl-4-propan-2-yl-1,2-thiazole;1-methyl-5-propan-2-yltriazole;2-propan-2-yl-1,3-oxazole;5-propan-2-yl-1,3-oxazole;2-propan-2-yl-1,3-thiazole;4-propan-2-yl-3-(trifluoromethyl)-1,2-oxazole |
| SMILES | CC(C)c1cnco1.CC(C)c1cnnn1C.CC(C)c1conc1C(F)(F)F.CC(C)c1nccn1C.CC(C)c1ncco1.CC(C)c1nccs1.CC(C)c1nnnn1C.Cc1nc(C(C)C)no1.Cc1ncoc1C(C)C.Cc1nnc(C(C)C)s1.Cc1nnc(C)n1C(C)C.Cc1nnnn1C(C)C.Cc1noc(C(C)C)n1.Cc1noc(C)c1C(C)C.Cc1nocc1C(C)C.Cc1nonc1C(C)C.Cc1nsc(C(C)C)n1.Cc1nsc(C)c1C(C)C.Cc1nscc1C(C)C |
| InChI | InChI=1S/C8H13NO.C8H13NS.C7H8F3NO.C7H13N3.C7H12N2.2C7H11NO.C7H11NS.C6H11N3.3C6H10N2O.2C6H10N2S.2C6H9NO.C6H9NS.2C5H10N4/c2*1-5(2)8-6(3)9-10-7(8)4;1-4(2)5-3-12-11-6(5)7(8,9)10;1-5(2)10-6(3)8-9-7(10)4;1-6(2)7-8-4-5-9(7)3;1-5(2)7-6(3)8-4-9-7;2*1-5(2)7-4-9-8-6(7)3;1-5(2)6-4-7-8-9(6)3;1-4(2)6-7-5(3)9-8-6;1-4(2)6-7-5(3)8-9-6;1-4(2)6-5(3)7-9-8-6;1-4(2)6-8-7-5(3)9-6;1-4(2)6-7-5(3)8-9-6;1-5(2)6-3-7-4-8-6;2*1-5(2)6-7-3-4-8-6;1-4(2)5-6-7-8-9(5)3;1-4(2)9-5(3)6-7-8-9/h2*5H,1-4H3;3-4H,1-2H3;5H,1-4H3;4-6H,1-3H3;4*4-5H,1-3H3;5*4H,1-3H3;3*3-5H,1-2H3;2*4H,1-3H3 |
| InChIKey | KSWBJSRWQPWVGA-UHFFFAOYSA-N |
| XLogP | 34.06 |
| TPSA | 529.61 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 49 |
| Rotatable Bonds | 19 |
| Heavy Atoms | 174 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2518.51 |
| LogP ≤ 5 | 34.06 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 49 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 163722623 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.